TGA appointments
August 14, 2013
THE Therapeutic Goods
Administration has announced a
number of changes in its senior
executive ranks, including the
appointment of Dr Lisa Studdert as
Head of the Market Authorisation
group, which manages premarket
activities in complementary, OTC
and prescription medicines as well
as medical devices and biologicals.
Dr Peter Bird has also been
appointed as the TGA’s Head,
Office of Medicines Authorisation,
confirming the role in which he’s
been acting for the last ten months.
Bill Turner is now Head, Office of
Scientific Evaluation, while Dr Laura
Kelly has been appointed as Head
of the Monitoring and Compliance
group, which manages postmarket
product vigilance activities,
laboratories and GMP inspections.
Dr Mark McDonald has become
Head, Office of Laboratory and
Scientific Services, and Dr Harry
Rothenfluh will lead the Office of
Manufacturing Quality when he
returns in Nov after a year heading
the WHO Prequalification of
Medicines Program.
Former National Capital Authority
ceo Gary Rake is now the TGA’s
Chief Operating Officer, while Judy
Develin will lead the agency’s new
Office of Change and Program
Management and Margaret Lyons
is heading up the ANZTPA Taskforce
from DOHA’s central Woden office.
And the Office for TGA-ANZTPA
will be led by Dr Cheryl McRae.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Aug 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Aug 13
